Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ranft

Showing results (271-280 of 283) with videos related to

Pageof 29
Sort By:
Nature Communications|September 17, 2021
Therapeutic targeting of the PLK1-PRC1-axis triggers cell death in genomically silent childhood cancerJing Li, Shunya Ohmura, Aruna Marchetto, et al.
Nature Human Behaviour|January 28, 2026
Convergent transcriptomic and connectomic controllers of information integration and its anaesthetic breakdown across mammalian brainsAndrea I Luppi, Lynn Uhrig, Jordy Tasserie, et al.
Ebiomedicine|August 21, 2019
Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patientsGiuseppina Sannino, Aruna Marchetto, Andreas Ranft, et al.
Science Advances|June 14, 2023
In vivo mapping of pharmacologically induced functional reorganization onto the human brain's neurotransmitter landscapeAndrea I Luppi, Justine Y Hansen, Ram Adapa, et al.
Environment International|October 15, 2014
Prenatal exposure to PCB-153, p,p'-DDE and birth outcomes in 9000 mother-child pairs: exposure-response relationship and effect modifiersMaribel Casas, Mark Nieuwenhuijsen, David Martínez, et al.
BMC Cancer|September 28, 2018
Genetic variation in gonadal impairment in female survivors of childhood cancer: a PanCareLIFE study protocolAnne-Lotte L F van der Kooi, Eva Clemens, Linda Broer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2022
High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing SarcomaRaphael Koch, Hans Gelderblom, Lianne Haveman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2023
Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 TrialRaphael Koch, Lianne Haveman, Ruth Ladenstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 7, 2018
High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008Jeremy Whelan, Marie-Cecile Le Deley, Uta Dirksen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2019
High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008Uta Dirksen, Bernadette Brennan, Marie-Cécile Le Deley, et al.
Pageof 29

Showing results (271-280 of 283) with videos related to

Sort By:
Pageof 29
Nature Communications|September 17, 2021
Therapeutic targeting of the PLK1-PRC1-axis triggers cell death in genomically silent childhood cancerJing Li, Shunya Ohmura, Aruna Marchetto, et al.
Nature Human Behaviour|January 28, 2026
Convergent transcriptomic and connectomic controllers of information integration and its anaesthetic breakdown across mammalian brainsAndrea I Luppi, Lynn Uhrig, Jordy Tasserie, et al.
Ebiomedicine|August 21, 2019
Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patientsGiuseppina Sannino, Aruna Marchetto, Andreas Ranft, et al.
Science Advances|June 14, 2023
In vivo mapping of pharmacologically induced functional reorganization onto the human brain's neurotransmitter landscapeAndrea I Luppi, Justine Y Hansen, Ram Adapa, et al.
Environment International|October 15, 2014
Prenatal exposure to PCB-153, p,p'-DDE and birth outcomes in 9000 mother-child pairs: exposure-response relationship and effect modifiersMaribel Casas, Mark Nieuwenhuijsen, David Martínez, et al.
BMC Cancer|September 28, 2018
Genetic variation in gonadal impairment in female survivors of childhood cancer: a PanCareLIFE study protocolAnne-Lotte L F van der Kooi, Eva Clemens, Linda Broer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2022
High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing SarcomaRaphael Koch, Hans Gelderblom, Lianne Haveman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2023
Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 TrialRaphael Koch, Lianne Haveman, Ruth Ladenstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 7, 2018
High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008Jeremy Whelan, Marie-Cecile Le Deley, Uta Dirksen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2019
High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008Uta Dirksen, Bernadette Brennan, Marie-Cécile Le Deley, et al.
Pageof 29